Announcements Trials
Browse Landscape

Status

Completed 2Available 2Unknown 1Approved for marketing 1

Sponsor Class

OTHER 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

CNS 2Endocrine 1

Conditions

Neuroblastoma 4Recurrence 2Pheochromocytoma 2Paraganglioma 1Neoplasms 1

Interventions

3-Iodobenzylguanidine 2Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Recurrence × 3-Iodobenzylguanidine × Clear all
NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Northwell Health

Available
CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡